BB BIOTECH AG, CH0038389992

EQS-NVR: BB BIOTECH AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

15.06.2026 - 07:00:03 | dgap.de

BB BIOTECH AG / CH0038389992

EQS Total Voting Rights Announcement: BB BIOTECH AG / Total Voting Rights Announcement
BB BIOTECH AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

15.06.2026 / 07:00 CET/CEST
Total Voting Rights Announcement transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

Publication of new total number of voting rights according to Sec. 41 WpHG

1. Details of issuer
BB BIOTECH AG
Schwertstrasse 6
8200 Schaffhausen
Switzerland

2. Type of capital measure or other measure
  Type of capital measure or other measure Date of status / date of effect
  Conditional capital increase (Sec. 41 para. 2 WpHG)
X Other (capital) measure (Sec. 41 para. 1 WpHG) 15 Jun 2026

3. New total number of voting rights:
55149250
number of multiple voting rights thereof: 0


15.06.2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News
Language: English
Company: BB BIOTECH AG
Schwertstrasse 6
8200 Schaffhausen
Switzerland
Internet: www.bbbiotech.ch

 
End of News EQS News Service
2344176  15.06.2026 CET/CEST
en | CH0038389992 | BB BIOTECH AG | boerse | 69541712 |